title: Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
abstract: Oral submucous fibrosis (OSF) is a premalignant, fibrosing disorder of the mouth, pharynx, and oesophagus, with a malignant transformation rate of 7-13%. OSF is strongly associated with areca (betel) nut chewing and worldwide, over 5 million people are affected. As αvβ6 integrin is capable of promoting both tissue fibrosis and carcinoma invasion, we examined its expression in fibroepithelial hyperplasia and OSF. αvβ6 was markedly up-regulated in OSF, with high expression detected in 22 of 41 cases (p < 0.001). We investigated the functional role of αvβ6 using oral keratinocyte-derived cells genetically modified to express high αvβ6 (VB6), and also NTERT-immortalized oral keratinocytes, which express low αvβ6 (OKF6/TERT-1). VB6 cells showed significant αvβ6-dependent activation of TGF-β1, which induced transdifferentiation of oral fibroblasts into myofibroblasts and resulted in up-regulation of genes associated with tissue fibrosis. These experimental in vitro findings were confirmed using human clinical samples, where we showed that the stroma of OSF contained myofibroblasts and that TGF-β1-dependent Smad signalling was detectable both in keratinocytes and in myofibroblasts. We also found that arecoline, the major alkaloid of areca nuts, up-regulated keratinocyte αvβ6 expression. This was modulated through the M(4) muscarinic acetylcholine receptor and was suppressed by the M(4) antagonist, tropicamide. Arecoline-dependent αvβ6 up-regulation promoted keratinocyte migration and induced invasion, raising the possibility that this mechanism may support malignant transformation. Over 80% of OSF-related oral cancers examined had moderate/high αvβ6 expression. These data suggest that the pathogenesis of OSF may be epithelial-driven and involve arecoline-dependent up-regulation of αvβ6 integrin.
authors.affiliation: Faculty of Medicine, Southampton Cancer Research UK Centre, University of Southampton, Southampton, UK.
authors.forename: Karwan A
authors.initials: KA
authors.lastname: Moutasim
authors.forename: Veronika
authors.initials: V
authors.lastname: Jenei
authors.forename: Karen
authors.initials: K
authors.lastname: Sapienza
authors.forename: Daniel
authors.initials: D
authors.lastname: Marsh
authors.forename: Paul H
authors.initials: PH
authors.lastname: Weinreb
authors.forename: Shelia M
authors.initials: SM
authors.lastname: Violette
authors.forename: Mark P
authors.initials: MP
authors.lastname: Lewis
authors.forename: John F
authors.initials: JF
authors.lastname: Marshall
authors.forename: Farida
authors.initials: F
authors.lastname: Fortune
authors.forename: Waninayaka M
authors.initials: WM
authors.lastname: Tilakaratne
authors.forename: Ian R
authors.initials: IR
authors.lastname: Hart
authors.forename: Gareth J
authors.initials: GJ
authors.lastname: Thomas
mesh_terms: D000199:Actins / Q000378:metabolism; D000951:Antigens, Neoplasm / Q000096:biosynthesis* / Q000235:genetics; D001114:Areca / Q000737:chemistry*; D001115:Arecoline / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D018920:Coculture Techniques; D006801:Humans; D016023:Integrins / Q000096:biosynthesis* / Q000235:genetics; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism; D009062:Mouth Neoplasms / Q000378:metabolism / Q000473:pathology; D058628:Myofibroblasts / Q000166:cytology / Q000187:drug effects; D009914:Oral Submucous Fibrosis / Q000378:metabolism* / Q000473:pathology; D011230:Precancerous Conditions / Q000378:metabolism / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D000199:Actins; D000951:Antigens, Neoplasm; D016023:Integrins; D053773:Transforming Growth Factor beta1; C073878:integrin alphavbeta6; D001115:Arecoline